PRISM PMR (PRe- and post-operatIve Study of iMaging with Portable MR) is designed to further collect data and optimize the Swoop® system's real-world clinical utility in the operating room. The study ...
Available to all Swoop® AI-powered portable MRI system users, the PULSE subscription provides access to innovative tools that empower both clinical researchers and developers to advance the rapidly ...
Results from study presented at the 2023 Asia-Pacific Extracorporeal Life Support Organization (APELSO) meeting GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking ...
The Swoop system tackles a critical challenge in health care, limited access to affordable and prompt brain imaging. More than three billion people globally are affected by brain diseases, including ...
Eleven clinical studies presented at RSNA 2024 highlighted the growing clinician experience with the Swoop® system for imaging diverse patient groups in emergency departments and neuro ICUs. GUILFORD, ...
Health technology company Hyperfine is collaborating with Silicon Valley giant NVIDIA to leverage NVIDIA's AI expertise and rapid computing to strengthen Hyperfine's portable imaging technology, the ...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® ...
Hyperfine Swoop® system, via partner UpCare, earns national referencing from UniHA, France’s top hospital purchasing cooperative.
GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...
New subscription-based platform empowers a community of Swoop® system users worldwide to access advanced tools in support of imaging research and clinical studies in portable MRI. Hyperfine, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results